state
ministri
health
decemb
wuhan
municip
health
committe
hubei
provinc
china
notifi
identif
case
pneumonia
unknown
aetiolog
onset
decemb
includ
sever
case
share
histori
possibl
exposur
market
sell
shellfish
seafood
live
anim
wuhan
citi
identifi
sourc
outbreak
market
shut
januari
januari
chines
author
identifi
new
viru
coronavirida
famili
caus
agent
outbreak
temporarili
name
new
coronaviru
chines
author
share
gene
sequenc
viru
januari
januari
world
health
organ
declar
outbreak
china
global
public
health
emerg
februari
case
diagnos
china
major
cluster
provinc
hubei
case
notifi
outsid
china
http
wwwworldometersinfo
coronaviru
usual
associ
case
import
china
fig
report
fatal
rate
confirm
case
rang
although
data
must
interpret
caution
given
quickli
outbreak
evolv
age
distribut
reflect
low
incid
paediatr
age
group
associ
milder
cours
diseas
base
data
inpati
case
seri
publish
date
high
proport
hospitalis
adult
nearli
individu
die
underli
diseas
januari
case
infect
confirm
la
gomera
canari
island
spain
german
nation
close
contact
anoth
confirm
case
germani
februari
anoth
posit
case
detect
majorca
correspond
citizen
unit
kingdom
close
contact
case
franc
case
diagnos
spain
adult
mild
cours
spain
airport
direct
flight
wuhan
cancel
flight
wuhan
china
decreas
probabl
arriv
infect
individu
nevertheless
possibl
case
import
highrisk
area
may
still
aris
spain
current
circumst
estim
risk
import
case
emerg
spain
moder
recommend
present
current
document
base
adapt
guidanc
clinic
manag
sever
acut
respiratori
infect
publish
januari
turn
adapt
recommend
given
manag
sever
acut
respiratori
infect
suspect
involv
merscov
recent
publish
recommend
nation
clinic
research
center
child
health
de
china
expert
consensu
statement
guidelin
may
chang
outbreak
evolv
includ
case
definit
could
extend
larger
geograph
area
recommend
prevent
isol
protect
treatment
base
februari
chang
interim
name
sever
acut
respiratori
syndrom
coronaviru
coronaviru
infecti
diseas
sinc
human
coronavirus
hcov
first
identifi
virus
includ
hcov
hcov
hcov
hcov
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
recognis
caus
agent
broad
rang
respiratori
infect
hcov
hcov
first
describ
respect
combin
hcov
hcov
respons
upper
respiratori
tract
infect
usual
context
outbreak
human
coronaviru
preval
major
case
occur
children
year
often
detect
case
coinfect
respiratori
virus
make
difficult
establish
particular
role
diseas
virus
associ
greater
sever
diseas
requir
hospit
admiss
usual
due
bronchospasm
especi
children
underli
diseas
fatal
case
hcov
infect
immunocompromis
patient
sarscov
describ
relat
outbreak
origin
china
caus
death
case
requir
mechan
ventil
case
fatal
rate
high
mortal
patient
underli
diseas
merscov
viru
first
identifi
associ
similar
clinic
pictur
higher
fatal
rate
viru
fulli
erad
sporad
case
continu
emerg
zoonot
diseas
transmit
human
anim
vector
bat
case
sar
dromedari
camel
case
mer
although
case
humantohuman
transmiss
report
mainli
health
care
set
low
rate
transmiss
like
human
coronavirus
envelop
singlestrand
rna
viru
diamet
nm
round
oval
shape
exhibit
pleomorph
evid
high
sequenc
ident
percent
ident
genom
sarslik
coronaviru
found
bat
sequenc
main
protein
viral
envelop
also
exhibit
high
ident
sequenc
found
sarscov
physic
chemic
properti
viru
respons
fulli
establish
believ
sensit
ultraviolet
radiat
heat
instanc
base
previou
research
sarscov
merscov
viru
could
inactiv
heat
temperatur
c
min
use
solvent
effect
lipid
ethanol
disinfect
contain
chlorin
peroxyacet
acid
chloroform
chlorhexidin
main
sourc
infect
individu
infect
report
transmiss
incub
period
asymptomat
individu
viru
transmit
airborn
droplet
micron
diseas
individu
cough
speak
sneez
close
contact
anoth
potenti
sourc
transmiss
touch
mouth
nose
ocular
conjunctiva
contamin
hand
document
case
vertic
transmiss
case
infect
newborn
infect
mother
test
posit
h
post
birth
known
whether
viru
transmit
breastfeed
paediatr
case
document
date
less
frequent
milder
compar
adult
although
appear
full
spectrum
sever
possibl
paediatr
popul
report
fatal
case
children
famili
cluster
describ
salient
one
includ
case
children
one
mild
diseas
anoth
asymptomat
abnorm
imag
find
time
write
case
identifi
appli
criteria
present
tabl
person
investig
pui
meet
least
criteria
given
tabl
laboratoryconfirm
case
case
meet
laboratori
criteria
given
tabl
diagnosi
made
revers
transcript
pcr
rtpcr
detect
coronaviru
rna
sequenc
viral
genom
test
perform
pharyng
swab
nasopharyng
swab
appropri
children
sputum
stool
blood
specimen
viru
isol
airway
epitheli
cell
cultur
perform
referr
laboratori
recommend
use
respiratori
viral
panel
rule
coinfect
virus
especi
influenza
virus
although
sever
laboratori
differ
autonom
commun
spain
perform
microbiolog
diagnosi
sampl
posit
case
must
submit
centro
nacion
de
nation
microbiolog
centr
cnm
definit
confirm
sampl
must
store
transport
c
handl
categori
b
infecti
substanc
infect
may
present
mild
moder
sever
diseas
includ
sever
pneumonia
acut
respiratori
distress
syndrom
ard
sepsi
septic
shock
date
paediatr
case
describ
literatur
appear
milder
incub
period
last
day
median
day
case
patient
recov
week
paediatr
death
report
date
earli
identif
patient
sever
diseas
tabl
allow
prompt
deliveri
optimis
support
care
quick
safe
admiss
referr
intens
care
unit
accord
region
nation
criteria
protocol
tabl
present
frequent
laboratori
imag
abnorm
found
patient
overal
find
compat
viral
respiratori
infect
similar
viral
ill
influenza
patient
mild
diseas
hospit
admiss
may
necessari
unless
concern
rapid
deterior
discharg
patient
must
instruct
return
hospit
symptom
worsen
time
individu
fever
respiratori
manifest
short
breath
cough
histori
close
contact
probabl
confirm
case
day
preced
onset
close
contact
defin
follow
care
individu
probabl
confirm
case
case
symptomat
health
care
worker
use
appropri
protect
measur
famili
member
individu
similar
physic
contact
case
space
probabl
confirm
case
distanc
less
metr
case
symptomat
household
member
visit
airplan
close
contact
defin
passeng
seat
within
radiu
probabl
confirm
case
case
symptomat
member
crew
come
contact
case
see
appendix
gener
measur
appli
case
uncompl
infect
recommend
hospit
isol
monitor
patient
noninvas
vital
sign
monitor
includ
measur
oxygen
satur
sato
mean
puls
oximetri
perform
chest
radiograph
blood
test
cbc
cpr
pct
blood
cultur
blood
chemistri
includ
liver
enzym
electrolyt
coagul
blood
ga
analysi
placement
peripher
cathet
bronchodil
may
use
indic
base
find
physic
examin
wheez
prefer
deliv
metereddos
inhal
mdi
spacer
commonli
use
analges
paracetamol
ibuprofen
option
admit
one
parent
along
patient
may
consid
prefer
singl
individu
alway
one
would
stay
child
alway
adher
indic
precaut
mask
gown
glove
goggl
may
also
case
parent
child
infect
admit
togeth
addit
intervent
mention
previou
section
conserv
fluid
manag
aggress
fluid
resuscit
may
worsen
oxygen
routin
fluid
therapi
suspect
confirm
infect
criteria
sir
includ
either
abnorm
bodi
temperatur
abnorm
white
blood
cell
count
septic
shock
degre
hypotens
sbp
percentil
sd
normal
age
follow
alter
mental
statu
tachycardia
bradycardia
hr
bpm
bpm
infant
bpm
bpm
children
prolong
capillari
refil
time
warm
shock
normal
puls
tachypnoea
mottl
skin
petechi
purpur
rash
lactat
elev
oliguria
hyperthermia
hypothermia
administr
baselin
requir
recommend
use
hypoton
salin
solut
hydroxyethyl
starch
gelatin
fluid
resuscit
supplement
oxygen
therapi
target
satur
case
suspect
bacteri
superinfect
leucocytosi
elev
cpr
pct
start
antibiotherapi
intraven
iv
amoxicillinclavulan
acid
admiss
picu
consid
patient
lower
respiratori
tract
infect
meet
criteria
definit
sever
diseas
extrapulmonari
manifest
associ
sever
ill
tabl
andor
exhibit
progress
worsen
recommend
hospit
ground
glass
opac
infiltr
discern
ct
compar
xray
possibl
avoid
ventil
bagvalvemask
system
absolut
necessari
use
system
high
effici
filter
selfinfl
bag
mask
prevent
viral
contamin
avoid
hyperventil
leak
intub
use
cuf
endotrach
tube
prevent
leak
cuff
pressur
cmh
requir
deliv
preoxygen
nonrebreath
mask
carri
rapid
sequenc
intub
intub
perform
experienc
staff
minimis
complet
time
number
intub
attempt
use
higheffici
filter
prevent
viral
contamin
inspiratori
expiratori
limb
use
close
suction
system
use
heatmoistur
exchang
fit
highefficaci
filter
prevent
viral
contamin
instead
activ
heat
humidifi
prevent
accident
disconnect
izat
isol
room
verifi
neg
pressur
perform
aerosolgener
procedur
tabl
necessari
provid
appropri
care
level
protect
heighten
due
increas
risk
contamin
staff
get
expos
kept
minimum
necessari
wear
mask
addit
longsleev
fluidresist
gown
fit
goggl
face
shield
glove
given
limit
inform
current
avail
mechan
transmiss
associ
risk
well
understood
addit
level
risk
occur
picu
would
reason
add
use
coveral
long
imperm
gown
hood
complet
avoid
exposur
gener
droplet
entir
care
team
support
staff
person
accompani
patient
picu
use
recommend
person
protect
equip
ppe
follow
establish
protocol
put
take
supervis
receiv
previou
train
ppe
relat
procedur
transport
rout
picu
predetermin
necessari
precaut
infect
control
measur
implement
transport
prevent
transmiss
transfer
process
hospit
stay
transport
patient
kept
minimum
perform
necessari
diagnost
examin
radiograph
ultrasound
scan
portabl
equip
isol
box
whenev
possibl
diagnost
equip
exclus
dedic
patient
disinfect
follow
prevent
medicin
guidelin
dispos
suppli
use
whenev
possibl
suppli
dispos
disinfect
follow
establish
protocol
medic
wast
care
patient
consid
biohazard
handl
dispos
follow
correspond
protocol
health
care
staff
plan
task
advanc
stay
room
minimum
time
requir
perform
possibl
staff
remain
least
away
patient
record
kept
everi
staff
member
come
contact
patient
base
current
knowledg
support
care
deliv
picu
sever
patient
present
ard
sepsi
organ
failur
significantli
differ
intern
guidelin
alreadi
exist
manag
condit
patient
requir
respiratori
support
noninvas
ventil
niv
pose
higher
risk
contamin
due
gener
aerosol
case
deterior
respiratori
function
use
invas
mechan
ventil
consid
follow
lungprotect
strategi
recommend
pediatr
acut
lung
injuri
consensu
confer
palicc
manag
ard
paediatr
popul
low
tidal
volum
mlkg
optimis
posit
endexpiratori
pressur
inspiratori
plateau
pressur
cmh
drive
pressur
less
cmh
permiss
hypercapnia
etc
prone
posit
necessari
neuromuscular
blockad
fluid
must
manag
appropri
avoid
fluid
overload
prevent
posit
balanc
associ
poorer
respiratori
outcom
increas
morbid
mortal
patient
sepsi
addit
cautiou
volum
expans
initi
resuscit
may
requir
vasoact
drug
deliv
adher
current
intern
paediatr
guidelin
patient
may
also
requir
continu
renal
replac
therapi
case
sever
respiratori
failur
cardiorespiratori
arrest
refractori
convent
treatment
use
extracorpor
membran
oxygen
ecmo
may
consid
base
indic
appli
health
condit
antibiotherapi
use
case
suspect
bacteri
superinfect
patient
sepsi
septic
shock
latter
case
essenti
antibiotherapi
given
within
one
hour
soon
possibl
regimen
individualis
consid
previou
condit
characterist
patient
comorbid
healthi
patient
mechan
ventil
etc
sampl
microbiolog
test
obtain
initi
antibiotherapi
whenev
possibl
rememb
withdraw
taper
treatment
necessari
base
result
case
describ
begin
outbreak
radiolog
evid
infiltr
everi
patient
receiv
empir
antibiotherapi
present
close
monitor
recommend
reserv
antibiotherapi
case
suspect
bacteri
superinfect
system
steroid
gener
recommend
previou
studi
patient
sar
mer
even
influenza
shown
offer
benefit
may
even
delay
viral
clearanc
use
consid
patient
ard
septic
shock
enceph
hemophagocyt
syndrom
sever
bronchospasm
associ
wheez
indic
recommend
iv
methylprednisolon
mgkgday
day
avoid
prolong
use
intraven
immunoglobulin
therapi
use
sever
case
indic
efficaci
need
evalu
recommend
dose
gkgday
day
mgkgday
day
specif
antivir
agent
proven
effect
case
infect
hcov
sar
mer
recommend
antivir
agent
sever
drug
current
tri
experiment
basi
oseltamivir
neuraminidas
inhibitor
use
case
merscov
infect
oseltamivir
use
initi
respons
outbreak
china
efficaci
clear
may
use
manag
influenza
coinfect
use
recommend
present
inhal
interferonalfa
recommend
combin
antivir
therapi
lopinavirritonavir
adult
clinic
trial
set
assess
efficaci
interferonalfa
broadspectrum
antivir
effect
use
treat
hepat
b
viru
formul
drug
inhal
current
avail
spain
chines
guidelin
recommend
nebulis
dose
iukg
mild
case
iukg
sever
case
given
twice
day
day
lopinavir
proteas
inhibitor
use
manag
hiv
combin
ritonavir
booster
lopinavir
andor
lopinavirritonavir
exhibit
activ
coronaviru
vitro
manag
sar
outbreak
hong
kong
evid
compar
ribavirin
alon
treatment
lopinavirritonavir
plu
ribavirin
decreas
risk
ard
death
remdesivir
could
best
possibl
option
treatment
antivir
agent
origin
develop
fight
ebola
class
nucleotid
analogu
experi
anim
infect
merscov
found
reduc
viral
titr
improv
lung
tissu
damag
anim
treat
remdesivir
compar
control
outcom
better
group
treat
remdesivir
compar
group
treat
lopinavirritonavir
combin
phase
iii
clinic
trial
remdesivir
treatment
infect
ebola
viru
complet
ampl
data
pharmacokinet
safeti
howev
efficaci
safeti
remdesivir
patient
infect
remain
establish
drug
avail
spain
unit
state
use
least
one
patient
favour
result
drug
chloroquin
antimalari
baricitinib
janu
kinas
inhibitor
consid
altern
treatment
option
although
use
assess
clinic
trial
conclus
current
evid
support
use
antivir
therapi
specif
antivir
agent
tabl
present
dosag
differ
antivir
agent
follow
could
consid
mild
case
requir
uncompl
manag
consid
oseltamivir
case
coinfect
influenza
earli
stage
anoth
possibl
option
lopinavirritonavir
sever
case
requir
hospit
admiss
consid
initi
treatment
lopinavirritonavir
remdesivir
obtain
may
use
sever
case
import
take
account
lopinavir
ritonavir
often
caus
gastrointestin
advers
event
treatment
initi
diarrhoea
vomit
author
declar
conflict
interest
